title: Treatment of multicentric reticulohistiocytosis with adalimumab, minocycline, methotrexate.
authors: Karen C
authors: KC
authors: Yeter
authors: Daniel G
authors: DG
authors: Arkfeld
mesh_terms: D000068879:Adalimumab; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D015616:Histiocytosis, Non-Langerhans-Cell / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008297:Male; D008727:Methotrexate / Q000627:therapeutic use*; D008875:Middle Aged; D008911:Minocycline / Q000627:therapeutic use*; D012074:Remission Induction; D012871:Skin Diseases / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology
chemical_list: D000900:Anti-Bacterial Agents; D000893:Anti-Inflammatory Agents; D061067:Antibodies, Monoclonal, Humanized; D007166:Immunosuppressive Agents; D000068879:Adalimumab; D008911:Minocycline; D008727:Methotrexate